Oppenheimer & Co. Inc. Has $132,000 Holdings in Enhabit, Inc. (NYSE:EHAB)

Oppenheimer & Co. Inc. lowered its stake in Enhabit, Inc. (NYSE:EHAB) by 26.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,699 shares of the company’s stock after selling 6,000 shares during the period. Oppenheimer & Co. Inc.’s holdings in Enhabit were worth $132,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. SummerHaven Investment Management LLC lifted its position in shares of Enhabit by 2.8% during the 2nd quarter. SummerHaven Investment Management LLC now owns 61,508 shares of the company’s stock worth $549,000 after purchasing an additional 1,660 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Enhabit by 5.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 37,950 shares of the company’s stock worth $443,000 after purchasing an additional 2,078 shares during the last quarter. Quarry LP lifted its position in shares of Enhabit by 242.2% during the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after purchasing an additional 2,621 shares during the last quarter. Gladius Capital Management LP acquired a new position in shares of Enhabit during the 2nd quarter worth about $31,000. Finally, Bank of New York Mellon Corp lifted its position in shares of Enhabit by 1.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 400,575 shares of the company’s stock worth $3,573,000 after purchasing an additional 5,936 shares during the last quarter.

Analyst Ratings Changes

Separately, Leerink Partners reissued a “market perform” rating and set a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating and six have given a hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $9.25.

Enhabit Trading Up 1.2 %

Enhabit stock opened at $7.56 on Friday. The business has a 50 day moving average price of $7.50 and a two-hundred day moving average price of $8.40. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The stock has a market cap of $380.12 million, a price-to-earnings ratio of -3.26 and a beta of 1.84. Enhabit, Inc. has a 12 month low of $6.85 and a 12 month high of $11.74.

Enhabit (NYSE:EHAB) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The firm had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same period last year, the company earned $0.03 EPS. As a group, equities analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.